Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP300497.RAqTe41loE1YvrQGGN9o3nxA8_P3fDs0g3gCBcDiZD5Lk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP300497.RAqTe41loE1YvrQGGN9o3nxA8_P3fDs0g3gCBcDiZD5Lk130_assertion type Assertion NP300497.RAqTe41loE1YvrQGGN9o3nxA8_P3fDs0g3gCBcDiZD5Lk130_head.
- NP300497.RAqTe41loE1YvrQGGN9o3nxA8_P3fDs0g3gCBcDiZD5Lk130_assertion wasGeneratedBy ECO_0000203 NP300497.RAqTe41loE1YvrQGGN9o3nxA8_P3fDs0g3gCBcDiZD5Lk130_provenance.
- NP300497.RAqTe41loE1YvrQGGN9o3nxA8_P3fDs0g3gCBcDiZD5Lk130_assertion wasDerivedFrom befree-20140225 NP300497.RAqTe41loE1YvrQGGN9o3nxA8_P3fDs0g3gCBcDiZD5Lk130_provenance.
- NP300497.RAqTe41loE1YvrQGGN9o3nxA8_P3fDs0g3gCBcDiZD5Lk130_assertion SIO_000772 10318905 NP300497.RAqTe41loE1YvrQGGN9o3nxA8_P3fDs0g3gCBcDiZD5Lk130_provenance.
- NP300497.RAqTe41loE1YvrQGGN9o3nxA8_P3fDs0g3gCBcDiZD5Lk130_assertion evidence source_evidence_literature NP300497.RAqTe41loE1YvrQGGN9o3nxA8_P3fDs0g3gCBcDiZD5Lk130_provenance.
- NP300497.RAqTe41loE1YvrQGGN9o3nxA8_P3fDs0g3gCBcDiZD5Lk130_assertion description "[Using AG879, a HER2/Neu inhibitor, and PD98059, a MAP kinase inhibitor, as well as MAP kinase phosphatase-1 (MPK-1), in the transfection assay, we found that HER2/Neu could induce prostate-specific antigen (PSA), a marker for the progression of prostate cancer, through the MAP kinase pathway at a low androgen level.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP300497.RAqTe41loE1YvrQGGN9o3nxA8_P3fDs0g3gCBcDiZD5Lk130_provenance.